SCHEMBL5885156

SCHEMBL5885156

CON(C)C(=O)C(O)C(N)Cc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.52
LAP3 P28838 5/20 0.49
ANPEP P15144 4/20 0.49
RNPEP Q9H4A4 1/20 0.49
DNPEP Q9ULA0 1/20 0.49
FAAH O00519 1/20 0.47
SLC15A1 P46059 1/20 0.46
ALPI P09923 1/20 0.44
PKM P14618 1/20 0.44
PTGS1 P23219 1/20 0.44
XIAP P98170 1/20 0.44
SLC7A5 Q01650 1/20 0.44
HPGD P15428 1/20 0.43
METAP2 P50579 2/20 0.43
CSNK1E P49674 1/20 0.41
SRR Q9GZT4 1/20 0.41
SLC1A3 P43003 1/20 0.41
SLC1A2 P43004 1/20 0.41
SLC1A1 P43005 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6350217 0.99 LTA4H (0.51) LTA4HLAP3ANPEPRNPEPDNPEP
SCHEMBL6359387 0.84 LAP3 (0.54) LTA4HLAP3ANPEPRNPEPDNPEP
SCHEMBL3131492 0.84 LAP3 (0.54) LTA4HLAP3ANPEPRNPEPDNPEP
SCHEMBL5885085 0.84 FAAH (0.46) LTA4HLAP3ANPEPRNPEPDNPEP
SCHEMBL6352728 0.84 FAAH (0.46) LTA4HLAP3ANPEPRNPEPDNPEP
SCHEMBL7269254 0.83 SLC7A5 (0.56) LTA4HLAP3FAAHSLC15A1ALPI
SCHEMBL7438290 0.83 SLC7A5 (0.56) LTA4HLAP3FAAHSLC15A1ALPI
SCHEMBL7842354 0.82 FAAH (0.47) LTA4HLAP3ANPEPFAAHSLC15A1
Hydrochloric Acid SCHEMBL6161681 0.82 SLC7A5 (0.54) LTA4HLAP3ANPEPRNPEPDNPEP
Hydrochloric Acid SCHEMBL1126065 0.82 SLC7A5 (0.54) LTA4HLAP3ANPEPRNPEPDNPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6992101-B2 N-(indole-2-carbonyl) and H-thieno[2,3-b]pyrrole-5-carboxamide anti-diabetic agents PFIZER, INC. (US) 2006-01-31 US disclosed
EP-1562899-A2 N-(INDOLE-2-CARBONYL)AMIDES AS ANTI-DIABETIC AGENTS Pfizer Products Inc. (US) 2005-08-17 EP disclosed
US-20040157907-A1 Anti-diabetic agents PFIZER INC 2004-08-12 US disclosed
WO-2004041780-A2 N-(INDOLE-2-CARBONYL) AMIDES AS ANTI-DIABETIC AGENTS PFIZER PRODUCTS INC. (US) 2004-05-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157907-A1 Anti-diabetic agents GPR119, INSR, IRS1 LTA4H 1813/4885LAP3 2259/4885ANPEP 2937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.